ersonal use only
Investor presentation
H1 FY22 results
Raj Naran, Managing Director and CEO
Luis Damasceno, Chief Financial Officer
17 November 2021
Right Solutions • Right Partner
www.alsglobal.com
IMPORTANT NOTICE AND DISCLAIMER
- This presentation has been prepared by ALS Limited, (ALS or the Company). It contains general information about the Company's activities as at the date of the | |||||
only | presentation. It is information given in summary form and does not purport to be complete. The distribution of this presentation in jurisdictions outside Australia | ||||
may be restricted by law, and you should observe any such restrictions. | |||||
- This presentation is not, and nothing in it should be construed as, an offer, invitation or recommendation in respect of securities, or an offer, invitation or | |||||
recommendation to sell, or a solicitation of an offer to buy, securities in any jurisdiction. Neither this document nor anything in it shall form the basis of any | |||||
contract or commitment. This presentation is not intended to be relied upon as advice to investors or potential investors and does not take into account the | |||||
investment objectives, financial situation or needs of any investor. All investors should consider such factors in consultation with a professional advisor of their | |||||
use | choosing when deciding if an investment is appropriate. | ||||
- The Company has prepared this presentation based on information available to it, including information derived from public sources that have not been | |||||
independently verified. No representation or warranty, express or implied, is provided in relation to the fairness, accuracy, correctness, completeness or reliability | |||||
of the information, opinions or conclusions expressed herein. | |||||
- This presentation includes forward-looking statements within the meaning of securities laws. Any forward-looking statements involve known and unknown risks | |||||
and uncertainties, many of which are outside the control of the Company and its representatives. Forward-looking statements may also be based on estimates and | |||||
ersonal | assumptions with respect to future business decisions, which are subject to change. Any statements, assumptions, opinions or conclusions as to future matters | ||||
may prove to be incorrect, and actual results, performance or achievement may vary materially from any projections and forward-looking statements. | |||||
- Due care and attention should be undertaken when considering and analysing the financial performance of the Company. | |||||
- All references to dollars are to Australian currency unless otherwise stated. | |||||
2 | Investor Presentation. Half Year Results H1 FY22 | Right Solutions • Right Partner | |||
Our sustainability programs
ersonal use only
Sustainability vision:
Deliver world-class health and safety outcomes, and attract a diverse, capable and engaged workforce.
People
Minimise our environmental footprint and build our resilience to climate-related impacts.
Environment
Make a positive contribution to our local communities.
Society
Operate ethically and responsibly to deliver sustainable outcomes for our stakeholders.
Governance
Caring for our people through:
A safe and healthy workplace
Positively contributing to society
COVID-19 Testing | Community programs |
Extraction of genetic material
Carbon Reduction Plan:
40% reduction in carbon intensity by 2030
40% reduction aligned to limiting global warming to 1.5oC.
Target Alignment
Switch to renewables.
Invest in solar.
Electricity
Vehicle safety and efficiency standard.
Fleet Efficiency
Facilities fit out sustainability standard.
Building Sustainability
3
Our commitment to climate action:
We aim to be carbon neutral in FY23
Investor Presentation. Half Year Results H1 FY22 | Right Solutions • Right Partner |
ESG program - FY22 progress
People | |||
Health & Safety | Training & Development | ||
Safety Culture/Life Saving Rules | Investing in talent development | Substantial improvement in injury frequency rate. |
only | Implementation of Women in Leadership Program. | |||||||||||
Diversity & Equality | Innovation & Technology | |||||||||||
Respecting differences | Embracing innovation and technology | |||||||||||
Supportive Work Environment | Hazard observations reporting substantially increased. | |||||||||||
Environment | Commenced installation of 11 solar PV systems for FY2022. | |||||||||||
Climate Change | Operational Environmental | Continued rollout of our LED lighting program across our facilities. | ||||||||||
CO₂ and Greenhouse Gas emissions | Performance | |||||||||||
Task Force on Climate Related Financial | Management of adverse environmental | |||||||||||
Disclosures (TCFD) | Commenced procurement of renewable energy across multiple countries. | |||||||||||
emissions | ||||||||||||
Efficient buildings, plant and equipment | ||||||||||||
use | Efficient operations | Pilot fume cupboard efficiency program in progress. | ||||||||||
Waste Reduction | ||||||||||||
Reduce, reuse, recycle | ||||||||||||
Society | ||||||||||||
Economic Contributions | Local Contribution | COVID testing for humans, wastewater and surfaces. | ||||||||||
Paying our fair share of tax | Community Sponsorships | Partnering with local schools and universities to promote science | ||||||||||
Donations and Sponsorships | ALS Cares | education. | ||||||||||
Science Education Programs | ||||||||||||
Human Rights | ||||||||||||
Local Employment | ALS Cares workplace giving program. | |||||||||||
ersonal | ||||||||||||
Worker's rights upheld / | ||||||||||||
Modern Slavery Assessments | Internal training plan on Modern Slavery Risks developed. | |||||||||||
Governance | ||||||||||||
Financial Performance | Regulatory Compliance | |||||||||||
Maximise return for shareholders | Systems to maintain legal compliance | Meeting or exceeding Corporations Act and ASX Guideline | ||||||||||
Anti-bribery & anti-corruption | ||||||||||||
requirements. | ||||||||||||
Conduct & Culture | ||||||||||||
Data integrity and traceability | Innovation & Technology | External assurance assessment of FY21 Sustainability Report | ||||||||||
Ethical business conduct | Strategy, investment & collaboration / | completed. | ||||||||||
Service lifecycle management | ||||||||||||
Enterprise Risk Management | ||||||||||||
Cybersecurity analysis completed. | ||||||||||||
Management of external strategic, financial, | ||||||||||||
and operational risks | ||||||||||||
4 | Investor Presentation. Half Year Results H1 FY22 | Right Solutions • Right Partner | ||||||||||
Group H1 FY22 performance vs strategic priorities
Shorter-term strategic priorities | H1 FY22 performance | ||
Life Sciences | |||
only | ➢ | Total revenue growth of +19.0% (+17.8% organic revenue growth) | |
Strong revenue growth and margin expansion | Underlying EBIT margin of +17.7%, +131 bps vs pcp | ||
➢ | |||
Commodities | |||
Strong revenue growth and margin expansion | ➢ Total revenue growth of +37.7% (+41.0% organic revenue growth) | ||
Underlying EBIT margin of 29.9%, expansion of +519 bps vs pcp | |||
➢ | |||
Increase market-leading position in Geochemistry | ➢ +46% sample volume vs pcp, +27% vs H1 FY20 | ||
use | Underlying EBIT margin of 33.4% | ||
➢ | |||
Industrial | |||
Improve organic revenue growth and stabilise margin | ➢ +3.0% organic revenue growth with margin decrease of (199) bps margin vs pcp | ||
Longer-term strategic priorities | H1 FY22 performance | |||||
Improve sustainability profile of the Group | ➢ Launched climate change policy targeting 40% reduction in scope 1 and 2 emissions by 2030 | |||||
➢ Aim to be carbon neutral in FY23 | ||||||
Non-cyclical businesses contribute 50% of Group underlying EBIT | ➢ 48% underlying EBIT contribution in H1 FY22 (56% in H1 FY21) | |||||
at the top of the commodity cycle | ||||||
Strong balance sheet to fund growth of Group | ➢ Lowest leverage ratio (1.5x) in 5 years with ~$720m of liquidity available to fund growth | |||||
➢ Completion of acquisition of Nuvisan in October 2021 (not included in H1 FY21), significantly expanding | ||||||
Strategic acquisitions in key growth markets | Pharmaceutical service offering | |||||
➢ Highly disciplined acquisition strategy | ||||||
Investment in technology and innovation | ➢ Continued investment across businesses with targeted capex spending on automation, technical | |||||
infrastructure (such as 'LIMS' and ERP platforms) and expansion of capacity | ||||||
5 | Investor Presentation. Half Year Results H1 FY22 | Right Solutions • Right Partner | ||||
ersonal |
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
ALS Limited published this content on 16 November 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 16 November 2021 22:16:15 UTC.